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Dr Shunji Sano (Okayama City, Japan). I congratulate
Dr Barron and his group on their excellent results. They presented
the results of first-stage palliation of HLHS. Their experience with
153 patients over a 4.5-year period shows a 30-day mortality of
12% on right-sided RV–PA, 25% on the left side, and 30% in the
control group. They also demonstrated a significant survival benefit
in the RV–PA group. No difference in ventricular function was
seen between groups. No regional dyskinesia was associated with
the RV–PA shunt. Central PA stenosis has the advantage of an
RV–PA shunt, especially on the left side.
Since 1998, 61 consecutive patients underwent RV–PA shunts
in our unit, and all patients had a left-sided RV–PA shunt. Our
30-day mortality is 6.6%, and 6-month mortality is 10%. Forty-
seven patients underwent the bidirectional Glenn procedure, and
PA plasty was required in 17 patients. Fourteen patients underwent
Hegar dilation only through a bidirectional Glenn anastomosis site.
Only 3 patients required patch angioplasty. Twenty-nine patients
have reached Fontan compression, with 8 patients requiring PA
plasty. Some of them had Hegar dilation only, and only 1 patient
required patch aortoplasty. Therefore of 61 patients, only 4 required
patch aortoplasty, and all 4 patients had reconstructed distal PA
stumps with autologous pericardium.
Therefore we changed our technique of distal PA anastomosis by
using a polytetrafluoroethylene cuff graft, which is already
reported. Since then, we have had no patients who required PA
patch aortoplasty.
As long as pulmonary blood flow is through an RV–PA shunt,
theoretically, there is not much difference if the shunt is right or
left sided. The reasons why I do RV–PA shunts to the left side
are that a left-sided shunt looks natural, it does not cross the aorta,
and the RV–PA shunt could be left open at the time of the bidirec-
tional Glenn procedure as additional flow if the PA is small, espe-
cially the left side.
I have a few questions for Dr Barron. First, I think everyone is
worried about compression of the graft if the graft crossed the neo-
aorta. Did you find any stenosis or obstruction in the graft?
Dr Barron. Thank you very much, Dr Sano. I should be stand-
ing here congratulating you over your results, too.
I think that you make a very valid point. All we can say is that we
have not encountered it as being a major problem because I think it
concerned us, too. We used delayed sternal closure, and we would
not close the chest until a patient had been in a persistent negative
fluid balance so that any of the original cardiac swelling had disap-
peared. Therefore we were not seeing acute obstruction to the shunt
when the chest was closed.ardiovascular Surgery c Volume 138, Number 3 535
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in 2 of 125 patients who have had the RV–PA shunt inserted, and
those 2 patients have both been treated with a coronary stent placed
at the time of catheterization to just buy extra time until the opera-
tion. Therefore I cannot say that we have been conscious of it being
a major issue with the patients.
Whether some of the interstage mortality was related, it is very
difficult for us to analyze interstage death, which is very frustrating,
but the histories of the patients would not suggest a thrombosis of
the shunt.
Dr Sano. In your article a central PA stenosis was 80% at the left
side and 62% at the right side. To me, the late or center pulmonary
stenosis is quite different from our experience. Could you describe
your technique of left-sided PA reconstruction. Also, you anasto-
mosed a shunt directly to the PA still with significant PA stenosis.
Therefore did you change your technique of distal PA anastomosis
to avoid PA stenosis?
Dr Barron. We certainly recognize that we are seeing a high
incidence of PA stenosis and that it has not been reported by every-
body, and we do not quite understand why that should be.
Clearly, I think other centers have experienced this problem with
the PAs, and we can say that we are certainly aware of centers who
regard it as such a significant problem that they have reverted back
to doing the classical Norwood procedure because they were find-
ing it difficult to manage these cases.
In terms of whether we changed our technique, we did try chang-
ing. We tried putting a patch first into the PAs and then putting
a shunt into the patch or putting the shunt directly into the PAs.
But we could not demonstrate any improvement. Although there
is a very high incidence of narrowing in the PA, many are only rel-
atively narrow. I am not sure whether everybody would consider
them meriting too much attention, but we would regard anything
more than a 25% reduction in diameter as requiring attention at
the time of the operation.
In terms of our technique for doing it, we would open the artery
as far as we could out into the hilum of the lung and repair it with
a PA patch.
Dr Sano. Finally, we reported that regurgitant flow ratio through
a 5-mm graft is 26% by using color Doppler echocardiographic
analysis. Did you measure regurgitant flow ratio in your series,
and was there any difference in the right-sided and left-sided shunts?
Dr Barron. The simple answer is that we did not, but it would be
very interesting to know that. Because, as you say, it might be that
some of the advantage of that longer shunt is that it reduces the
regurgitant fraction because the back resistance is that little bit
higher. But we did not measure it.
Dr Sano. I will just mention that the RV–PA shunt procedure
started only 9 years ago, and with refinement of the procedure,
the result has been proved in many institutions. I must say the
PA reconstruction is not easy, and we need more refinement.
Finally, I congratulate your excellent results and beautiful pre-
sentation, and I must thank the association for giving me the oppor-
tunity to discuss this important article.
DrArdawan Rastan (Leipzig, Germany). I appreciate your pre-
sentation very much, and it was really interesting. You have a huge
experience in these really demanding patients.
I have 2 questions. First, do you have any experience with
valved conduits? Second, do you have any experiences with or536 The Journal of Thoracic and Cardiovascular Sudo you have any problems with reoperations for stage II? Do you
have any injuries of the shunts, and do you have any protocols to
avoid any adhesions for these patients?
Dr Barron. We do not use valved conduits. I would be very
interested to see Dr Hanley’s series recently published using small
homografts in these patients, and certainly you could see the
hemodynamic benefits that might have. The simple truth is that
we do not have access to this type of small homograft in sufficient
numbers that we could use valved conduits, and therefore we have
not.
We have not had any problem in resternotomy in these patients.
It worried us going straight in with the conduit being very anterior.
I think the use of a pericardial Gore-Tex membrane has been very
helpful, but we have not had a single episode of injuring a heart on
reopening the sternum, and all the patients were started on bypass in
a routine fashion.
Dr James S. Tweddell (Milwaukee, Wis). Thanks, this was an
excellent study and an excellent presentation.
I think we actually do this in a way very similar to your tech-
nique. We also bring the conduit to the right side. I think the differ-
ence—and this might be important—is that we routinely patch the
distal pulmonary confluence. I also fully mobilize the PAs from
first branch to first branch to place the native PA segment actually
to the right of the ascending aorta as well.
I think that this was brought up as a potential factor last week at
the World Society of Pediatric and Congenital Heart Surgery. I do
not always remember who the author was, Jeff. Therefore it might
be that patching and the right-sided position are important. But
I thought your article was excellent and I just rise to add those 2
potential comments of ways to modify the technique.
My question is concerning your stage II strategy. Do you rou-
tinely clamp for that, and what is the need for that?
Dr Barron. Thank you.
In terms of patching the PAs, I am intrigued by patching the
PAs because it seems to make sense that we should be patching
them all. But when we analyzed this—we published our data last
year simply looking at patching the PAs at the time of the stage I
procedure (it was in a more historical cohort before the RV–PA
conduits)—we could not demonstrate that patching them or not
patching them, by closing the PAs directly, seemed to have
any influence on the morphology of the PAs afterward. We can-
not really explain that. I wonder whether there is such limited
room sometimes in the concavity of the arch underneath the re-
constructed aorta that the left PA gets kind of trapped a little be-
hind it and whether sometimes putting a patch in simply leaves
you too much tissue in there and the thing just gets folded and
caught between it.
Dr Tweddell. Well, I think you should put the distal conduit into
the patch.
Dr Barron. Into the patch. That might be a good point. And you
had a second question?
Dr Tweddell. Concerning the stage II procedure.
Dr Barron. It has been our policy—and that might be a rather
aggressive policy—that we tend to cool the patients right down
at stage II unless they have very straightforward anatomy and
have routinely used a period of circulatory arrest to reconstruct
the PAs and form the anastomosis. I think it is our philosophy
that we just want to make sure we get the PAs as good as wergery c September 2009
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maximum size.
Dr Emile A. Bacha (Boston, Mass). I have a comment and
a question.
Do you think the improved survival that you have shown is
a matter of a learning curve? It seems to me over the last few years
that you have been using a right-sided conduit and before that you
were using a left-sided conduit.
Dr Barron. Yes, there is no doubt that because the design is
a retrospective study with a historical control, it could well be.
What we could say is that we saw an immediate improvement in
our survival figures when we undertook the left RV–PA conduit.
Therefore that was early evidence that the hemodynamic benefit
was there straightaway and maybe there was not too much of
a learning curve.
Dr Bacha. The reason I am asking is that we also in Boston
mostly are doing a right-sided RV–PA conduit, and we have not
seen a change in survival, but we have definitely seen the greater
facility at stage II.The Journal of Thoracic and CThe comment I was going to make is that this conduit crossing
from the left to the right underneath the sternum can be trouble-
some sometimes in a stage II procedure. We have 2 patients
who had their stage I procedures at our institution and went on
to have a stage II procedure at another institution who both died
at the time of the redo operation when the surgeon sawed into
the conduit, and it is a difficult situation, and in a small baby, to
rescue these kids.
Dr Vaughn A. Starnes (Los Angeles, Calif). I have 1 quick
question. Did you notice a differential in time between when you
did your stage II procedure, in left versus right, as an indicator of
quality of shunt?
Dr Barron. No, there is no difference in time. Our mean time
is 22 weeks. What we have found is that we do the stage II pro-
cedure in the entire RV–PA conduit group slightly earlier than
we were doing it in the classical Norwood procedure group. I
think that is partly because we were anxious to see the anatomy
early on when we started the procedure, and it has just kind of
stuck with us.ardiovascular Surgery c Volume 138, Number 3 537
